These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14533077)

  • 21. Newer antiepileptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: An indirect comparison.
    Zhu LN; Chen D; Xu D; Tan G; Wang HJ; Liu L
    Seizure; 2017 Oct; 51():121-132. PubMed ID: 28854405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of levetiracetam in hospitalized patients.
    Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I
    Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy.
    Piazzini A; Chifari R; Canevini MP; Turner K; Fontana SP; Canger R
    Epilepsy Res; 2006 Mar; 68(3):181-8. PubMed ID: 16332430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
    García C; Rubio G
    Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients.
    Heo K; Lee BI; Yi SD; Huh K; Kim JM; Lee SA; Shin DJ; Song HK; Lee SK; Kim JY; Lu S; Dubois C; Tonner F
    Seizure; 2007 Jul; 16(5):402-9. PubMed ID: 17369059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
    Baulac M; Brodie MJ; Elger CE; Krakow K; Stockis A; Meyvisch P; Falter U
    Epilepsia; 2007 Mar; 48(3):589-92. PubMed ID: 17326794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adjunctive Therapy with Levetiracetam for Elderly Japanese with Partial Epilepsy: Effectiveness of Levetiracetam in Seizure Management of Epilepsy Patients with Advanced-age Onset in a Practical Setting].
    Yamauchi T; Kanemoto K; Kawai K; Ishida S; Yamada M; Tokumasu T; Shirai H; Yamamura K
    Brain Nerve; 2015 Jun; 67(6):749-58. PubMed ID: 26062590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
    von Stuelpnagel C; Holthausen H; Kluger G
    Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disfluent speech in patients with partial epilepsy: beneficial effect of levetiracetam.
    Sechi G; Cocco GA; D'Onofrio M; Deriu MG; Rosati G
    Epilepsy Behav; 2006 Nov; 9(3):521-3. PubMed ID: 16971185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levetiracetam extended release conversion to monotherapy for the treatment of patients with partial-onset seizures: a double-blind, randomised, multicentre, historical control study.
    Chung S; Ceja H; Gawłowicz J; Avakyan G; McShea C; Schiemann J; Lu S
    Epilepsy Res; 2012 Aug; 101(1-2):92-102. PubMed ID: 22516508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levetiracetam in patients with refractory epilepsy: results of the SKATE trial in Austria, Germany and Switzerland.
    Steinhoff BJ; Trinka E; Wieser HG;
    Seizure; 2005 Oct; 14(7):490-6. PubMed ID: 16169256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of intracerebral γ-aminobutyric acid (GABA) levels by titration with levetiracetam in patients with focal epilepsies.
    Doelken MT; Hammen T; Bogner W; Mennecke A; Stadlbauer A; Boettcher U; Doerfler A; Stefan H
    Epilepsia; 2010 Aug; 51(8):1477-82. PubMed ID: 20345933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks.
    Piña-Garza JE; Schiemann-Delgado J; Yang H; Duncan B; Hadac J; Hunter SJ
    Clin Ther; 2010 Oct; 32(11):1935-50. PubMed ID: 21095488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
    Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E
    Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy.
    Grosso S; Cordelli DM; Franzoni E; Coppola G; Capovilla G; Zamponi N; Verrotti A; Morgese G; Balestri P
    Seizure; 2007 Jun; 16(4):345-50. PubMed ID: 17368928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levetiracetam--a new drug for epilepsy.
    Drug Ther Bull; 2002 Apr; 40(4):30-2. PubMed ID: 11995265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levetiracetam-induced seizure aggravation associated with continuous spikes and waves during slow sleep in children with refractory epilepsies.
    Caraballo RH; Cersósimo R; De los Santos C
    Epileptic Disord; 2010 Jun; 12(2):146-50. PubMed ID: 20483715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.